NYSE American · Stocky rates: Cautious

National HealthCare Corporation (NHC)

$230.37 ▲ +1.19% as of 6 Oct, 10:51

Stocky turns companies like National HealthCare Corporation into a fun, safe way to learn investing — a virtual portfolio, live scores & charts, and real analyst data, with no real money.

Try Stocky free →
49
/ 100
Neutral

What Stocky thinks

Stocky rates National HealthCare Corporation at 49/100 based on business quality, leadership alignment, valuation.

Compounder Score
53/100
Business quality — profitability, growth, capital efficiency.
Resilience
50/100
Downside resilience — customer concentration, supply chain, refinancing risk.
Value Score
42/100
Valuation vs peers and history — is this a good price to pay?
A
Strong — comfortably financed.

How safely National HealthCare Corporation is financed, graded A++ (strongest) to C from the last five years of accounts: debt against earnings, interest cover, cash against debt, how high and steady profit margins are, return on capital, and whether it generated cash every year. Not part of the Stocky score.

What Stocky gives investors that other tools don't

Every stock is scored across six dimensions built to answer one question — can this business keep compounding? — without a Bloomberg subscription. Here's the actual snapshot for National HealthCare Corporation:

49
VERDICT

Stocky Verdict — one score, everything

Quality + moat + leadership + valuation fused into a single 0–100 number. When you see 49/100, you know instantly whether to dig deeper or skip.

Rated
MOAT

Moat Score — is there a real edge?

Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.

—
LEADER

Leadership Alignment — is management on your side?

Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.

50
RESILIENCE

Resilience Profile — what could break?

Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.

Elite
TRACK

Track Record — does the system work?

We don't claim a backtest. The top-scoring basket is recorded every month and measured against the S&P 500 from that date onward — judged on what it said before the outcome was known. The record is young, and published as it stands.

24/7
ALERTS

Alerts + Portfolio insights

Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.

National HealthCare Corporation (NHC) — frequently asked

Is National HealthCare Corporation (NHC) a good investment right now?

Stocky rates National HealthCare Corporation (NHC) at 49/100 — below the bar Stocky looks for. The score fuses business quality, moat width, leadership alignment, valuation into a single number.

What is NHC's Stocky Verdict?

NHC's current Stocky Verdict is 49/100, placing it in the "Cautious" band. This composite combines a 53/100 Compounder score, Leadership, Moat rating.

Does National HealthCare Corporation have a competitive moat?

Stocky hasn't finalised a Moat Score for National HealthCare Corporation yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.

Is National HealthCare Corporation's leadership aligned with shareholders?

Leadership Alignment for National HealthCare Corporation is under analysis. Stocky scores founder tenure, insider ownership, CEO compensation multiple-of-salary, and long-term shareholder value creation.

What are the biggest risks to NHC?

National HealthCare Corporation's Resilience Profile scores 50/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to National HealthCare Corporation.

This is just the surface. See the whole picture on National HealthCare Corporation.

Sign up free and unlock the full analysis on NHC — the same tools professional analysts use, personalised to your portfolio:

  • Every analyst covering NHC — full list with star ratings, price targets, historical hit-rate. Not just the top 3 you see above.
  • Full Resilience Profile — customer concentration, refinancing walls, stress-test scenarios (-20% revenue, +200bp rates) modelled specifically for NHC.
  • Bull & bear thesis — the AI-written counter-argument every retail investor forgets to read.
  • Portfolio fit check — how NHC changes your sector concentration, correlation and Verdict-weighted quality.
  • Ask Stocky AI — "What are the biggest 3-year risks to NHC?" · "Is NHC overvalued vs its 5-year median?" · unlimited follow-ups on your portfolio.
  • Live alerts — analyst target changes, insider buys, big moves — the day they happen.
Start free · 14 days Plus, no card →

Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.

STOCKY VERDICT
49
/ 100 · Neutral

See National HealthCare Corporation the Stocky way

This page is just a preview. Open the live, interactive version for the full picture:

Stocky Verdict
A plain-English Buy / Hold / Sell score out of 100.
Compounder & Value scores
How strong the business is — and whether it looks cheap.
Interactive charts
1M to 5Y price history with company events plotted on it.
Top analyst targets
What the best-rated Wall Street analysts expect next.
What if? simulator
See what an investment in NHC would be worth today.
Practice portfolio
Buy NHC with virtual money and track it — zero risk.
Free · no real money · learn by doing Open NHC in Stocky →

Or jump straight to the interactive dashboard for NHC in the app.